Search

everythinglearnresearchcommunity

for

Search:↓

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

The role of γδT-cells in causing alopecia areata remains unclear.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

People with acne have more CD4+ immune cells in their skin than healthy people.

JAK inhibitors might help treat alopecia areata.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Leukemia can sometimes appear as unusual skin issues in children.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Targeting specific T cells may help treat alopecia areata.

Clonally expanded CD8+ T cells cause alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

ITK inhibitors may effectively treat alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

The assay effectively identifies compounds that affect immune cell activation.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.